Table of Content


Introduction
Amyloidosis - Overview
Amyloidosis - Therapeutics Development
Amyloidosis - Therapeutics Assessment
Amyloidosis - Companies Involved in Therapeutics Development
Amyloidosis - Drug Profiles
Amyloidosis - Dormant Projects
Amyloidosis - Discontinued Products
Amyloidosis - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Amyloidosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Amyloidosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Amyloidosis - Pipeline by ADRx Inc, H2 2020
Amyloidosis - Pipeline by Akcea Therapeutics Inc, H2 2020
Amyloidosis - Pipeline by Alnylam Pharmaceuticals Inc, H2 2020
Amyloidosis - Pipeline by Amgen Inc, H2 2020
Amyloidosis - Pipeline by Auven Therapeutics Development Switzerland Sarl, H2 2020
Amyloidosis - Pipeline by Bristol-Myers Squibb Co, H2 2020
Amyloidosis - Pipeline by BSIM Therapeutics SA, H2 2020
Amyloidosis - Pipeline by Caelum Biosciences Inc, H2 2020
Amyloidosis - Pipeline by Chugai Pharmaceutical Co Ltd, H2 2020
Amyloidosis - Pipeline by Corino Therapeutics Inc, H2 2020
Amyloidosis - Pipeline by Covalent Bioscience Inc, H2 2020
Amyloidosis - Pipeline by Eidos Therapeutics Inc, H2 2020
Amyloidosis - Pipeline by Johnson & Johnson, H2 2020
Amyloidosis - Pipeline by Mabpharm Ltd, H2 2020
Amyloidosis - Pipeline by Neurimmune Holding AG, H2 2020
Amyloidosis - Pipeline by Oncopeptides AB, H2 2020
Amyloidosis - Pipeline by Precision Biosciences Inc, H2 2020
Amyloidosis - Pipeline by Proclara Biosciences Inc, H2 2020
Amyloidosis - Pipeline by Prothena Corp Plc, H2 2020
Amyloidosis - Pipeline by R Pharm, H2 2020
Amyloidosis - Pipeline by Regeneron Pharmaceuticals Inc, H2 2020
Amyloidosis - Pipeline by Sorrento Therapeutics Inc, H2 2020
Amyloidosis - Pipeline by Spectrum Pharmaceuticals Inc, H2 2020
Amyloidosis - Pipeline by Swedish Orphan Biovitrum AB, H2 2020
Amyloidosis - Pipeline by TheraPharm Deutschland GmbH, H2 2020
Amyloidosis - Pipeline by Vera Therapeutics Inc, H2 2020
Amyloidosis - Dormant Projects, H2 2020
Amyloidosis - Dormant Projects, H2 2020 (Contd..1), H2 2020
Amyloidosis - Discontinued Products, H2 2020